Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients (Q48508351)

12 February 2018

title

Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients (English)

1 reference

12 February 2018

0 references

0 references

1 reference

12 February 2018

author name string

M I Aparicio-Legarza

series ordinal

1 reference

12 February 2018

B Davis

series ordinal

1 reference

12 February 2018

P H Hutson

series ordinal

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

12 February 2018

number of pages

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

12 February 2018

volume

241

1 reference

12 February 2018

issue

2-3

1 reference

12 February 2018

page(s)

143-146

1 reference

12 February 2018

Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Kainate receptors in the rat hippocampus: a distribution and time course of changes in response to unilateral lesions of the entorhinal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

Elevated NMDA receptors in parkinsonian striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900017-2

7 January 2021

10.1016/S0304-3940(98)00017-2

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018